| Intuitive Announces CEO Transition Effective July 1, 2025 |
President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive's board Current Board Chair Craig Barratt to become lead independent director |
globenewswire.com |
2025-05-15 13:05:00 |
Czytaj oryginał (ang.) |
| ISRG Stock Gains More than 8% YTD: Will the Uptrend Continue? |
Shares of Intuitive Surgical ISRG seem to gain momentum after declining for more than two months. The stock has risen 9.7% in the past month after declining more than 30% from its all-time high of $616 in January. |
zacks.com |
2025-05-15 11:51:05 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It |
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
zacks.com |
2025-05-13 14:01:00 |
Czytaj oryginał (ang.) |
| Trade Tracker: Stephanie Link sells Eli Lilly and buys more Intuitive Surgical |
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves. |
youtube.com |
2025-05-12 17:21:43 |
Czytaj oryginał (ang.) |
| Prediction: 3 Stocks That Will Be Worth More Than Palantir Technologies 5 Years From Now |
Few stocks have sizzled as much as Palantir Technologies (PLTR -1.49%) over the last 12 months. Shares of the data analytics software provider more than quadrupled during the period. |
fool.com |
2025-05-10 09:45:00 |
Czytaj oryginał (ang.) |
| The Transformative Rise of Global Robotics: A 2025 Market Analysis |
Robotics is poised for robust growth in 2025. Watch NVDA, ISRG, SERV and PATH for potential market dominance across healthcare, manufacturing and mobility sectors. |
zacks.com |
2025-05-07 16:40:46 |
Czytaj oryginał (ang.) |
| Stock Picks From Seeking Alpha's April 2025 New Analysts |
In April, Seeking Alpha welcomed 20 new analysts. This article introduces them and showcases some of their top picks. Top picks include Palantir, Arch Capital Group, and Utah Medical Products, emphasizing an under-recognized growth driver, discounted valuation, and a substantial margin of safety. Analysts also highlighted Sell recommendations on Estée Lauder and Intuitive Surgical, citing deteriorating consumer sentiment and little price upside. |
seekingalpha.com |
2025-05-06 12:00:00 |
Czytaj oryginał (ang.) |
| 2 Stocks I Can't Wait to Buy During the Next Market Correction |
Investors never know when the next market correction -- a drop of from 10% to 20% in an index -- is coming, but we know that it will eventually happen. And because that's true, it makes sense to make a list of the stocks you'd like to buy if they dip during a correction. |
fool.com |
2025-05-06 08:41:00 |
Czytaj oryginał (ang.) |
| Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now |
In 2025, Wall Street has been rattled with increasing concerns about U.S.-China trade wars, escalating geopolitical pressures, rising economic uncertainties, and growing recession fears. The benchmark S&P 500 index is down nearly 4.7% in 2025. |
fool.com |
2025-05-05 11:00:00 |
Czytaj oryginał (ang.) |
| Prediction: 2 Stocks Will Be Worth More Than Palantir Technologies in 2026 |
Palantir Technologies is currently worth $269 billion. But these Wall Street analysts think Intuitive Surgical (ISRG 2.29%) and ServiceNow (NOW 2.00%) can top that figure in 2026: |
fool.com |
2025-05-03 08:04:00 |
Czytaj oryginał (ang.) |
| Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection |
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the da Vinci SP's capabilities in colorectal surgery, building upon procedures previously cleared by the FDA in November 2024, which include transabdominal procedures - low anterior resection, total mesorectal excision, colectomy, abdominoperineal resection, and sigmoidectomy. |
globenewswire.com |
2025-05-01 13:15:00 |
Czytaj oryginał (ang.) |
| Trump's Tariffs Could Impact This Top Growth Stock. Here's Why It's Still a Buy |
President Donald Trump's macroeconomic policies are creating significant uncertainty. His decision to impose sweeping tariffs on goods imported into the U.S. could harm the economy and specific corporations in ways that are scaring off investors. |
fool.com |
2025-05-01 09:30:00 |
Czytaj oryginał (ang.) |
| Baron Health Care Fund Q1 2025 Top Net Purchases And Sales |
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopharmaceutical quality control, new regulations, and product replacement cycles, targeting high single to low double-digit revenue growth. Penumbra's mechanical thrombectomy devices target underpenetrated markets with potential FDA approval for Thunderbolt device as a growth catalyst. |
seekingalpha.com |
2025-04-29 15:45:00 |
Czytaj oryginał (ang.) |
| Baron Health Care Fund Q1 2025 Top Contributors And Detractors |
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals saw increased investor confidence in its cystic fibrosis franchise and evolving pipeline, including promising non-opioid pain treatments and kidney disease drugs. UnitedHealth Group's shares gained as 2024 headwinds subsided, Medicare Advantage rates improved, and higher-margin Optum segments grew, insulating it from tariff impacts. |
seekingalpha.com |
2025-04-29 15:30:00 |
Czytaj oryginał (ang.) |
| ISRG vs. SYK: Which Robotic-Device Innovator Is a Better Buy? |
As robotic-assisted surgery becomes a cornerstone of modern healthcare, two medtech giants — Intuitive Surgical ISRG and Stryker SYK — are leading the charge. Intuitive, the pioneer behind the da Vinci Surgical System, has long dominated soft tissue procedures. |
zacks.com |
2025-04-29 14:15:48 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know |
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
zacks.com |
2025-04-29 14:01:07 |
Czytaj oryginał (ang.) |
| 2 Growth Stocks to Buy on the Dip if the Market Crashes Again |
Anxious investors who picked April to go on a long internet-free vacation couldn't have planned it better. Earlier this month, the S&P 500 index quickly sank more than 10% after President Donald Trump unveiled tariff rules that threatened the U.S. economy. |
fool.com |
2025-04-26 18:28:00 |
Czytaj oryginał (ang.) |
| Trade Tracker: Stephanie Link buys Intuitive Surgical |
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest buy of Intuitive Surgical |
youtube.com |
2025-04-25 17:03:38 |
Czytaj oryginał (ang.) |
| Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? |
Shares of Intuitive Surgical Inc. NASDAQ: ISRG are leveling off after some volatile price movement around the company's quarterly earnings. On April 22, the robotics surgery company delivered a beat on the top and bottom lines. |
marketbeat.com |
2025-04-25 12:16:37 |
Czytaj oryginał (ang.) |
| Intuitive Surgical: Decent Results But Waiting For An Entry Point |
Intuitive Surgical's Q1 2025 earnings showed mixed results, with revenue and EPS beating expectations, but gross margins impacted by tariffs and a lower-margin product mix. Procedure volume growth was strong, especially outside the US, and management raised full-year growth targets, indicating optimism despite macroeconomic uncertainties. The company's valuation is high, trading at 60x forward P/E, making it expensive; I'm looking for a lower entry point around 45x forward P/E. |
seekingalpha.com |
2025-04-25 11:27:21 |
Czytaj oryginał (ang.) |
| Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet |
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. |
zacks.com |
2025-02-26 12:30:49 |
Czytaj oryginał (ang.) |
| Stock-Split Watch: Is Intuitive Surgical Next? |
Investors are always on the lookout for the next stock split -- for a couple of reasons. These operations that increase the number of shares and reduce the per-share price accordingly often make it easier to invest in a high-flying stock. |
fool.com |
2025-02-22 06:45:00 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know |
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. |
zacks.com |
2025-02-20 12:00:44 |
Czytaj oryginał (ang.) |
| Recent Developments Show These 3 Growth Stocks Could Be Big Winners In 2025 |
As earnings season concludes, investors looking for meaningful catalysts to point to as reasons to own specific stocks certainly have plenty to think about. |
247wallst.com |
2025-02-20 10:55:26 |
Czytaj oryginał (ang.) |
| Intuitive Surgical is Known for Selling $1 Million Surgical Robots. But Here's How it Actually Makes Most of its Revenue. |
Intuitive Surgical (ISRG 1.26%)best known for its flagship da Vinci robot, is the global leader in the robotic surgery market. The da Vinci, available in several versions including the latest da Vinci 5, generates billions of dollars of revenue annually, and this performance has helped the company's stock soar over the near term and the long term. |
fool.com |
2025-02-20 06:10:00 |
Czytaj oryginał (ang.) |
| Final Trades: Toast, Nexstar Media Group, Salesforce and Intuitive Surgical |
The Investment Committee give you their top stocks to watch for the second half. |
youtube.com |
2025-02-18 15:42:16 |
Czytaj oryginał (ang.) |
| ISRG Nears $600: Can the Stock Breach the Mark Again This Month? |
Intuitive Surgical has maintained an uptrend in the past six months on the back of robust da Vinci portfolio performance. The stock has also gained during the past month. |
zacks.com |
2025-02-18 10:36:09 |
Czytaj oryginał (ang.) |
| The Ultimate Healthcare Robotics Stock to Buy With $600 Right Now |
Robotics is something that is transforming many industries -- and one of the biggest winners is the area of healthcare. Using robots in minimally invasive surgeries has been shown to decrease chances of complications, shorten hospital stays, and lower mortality rates. |
fool.com |
2025-02-15 20:10:00 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It |
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. |
zacks.com |
2025-02-07 12:01:21 |
Czytaj oryginał (ang.) |
| If You'd Invested $10,000 in Intuitive Surgical Stock 10 Years Ago, Here's How Much You'd Have Today |
Many of us occasionally look at an impressive stock that we don't own and wonder, "How much would I have today if I'd invested in it some years ago?" One company that those in the know might wonder about is Intuitive Surgical (ISRG -0.15%) -- a giant in the robotic surgery arena. |
fool.com |
2025-02-06 12:07:00 |
Czytaj oryginał (ang.) |
| Intuitive Surgical Just Posted a Solid Quarter, but This Is Why the Stock Could Be in Trouble This Year |
Intuitive Surgical (ISRG 1.94%) should arguably be doing a whole lot better after coming off the release of some strong earnings numbers. Business is doing well, the growth rate is solid, and in the long run, the company has a lot of potential. |
fool.com |
2025-02-06 07:06:00 |
Czytaj oryginał (ang.) |
| 2 Monster Stocks to Buy and Hold Forever |
It's hard to predict which way the market, or any specific company, will move in a short period, like a single year. But the longer we expand our horizon, the more likely it is that excellent companies, and equities in general, will deliver solid returns. |
fool.com |
2025-02-05 08:03:00 |
Czytaj oryginał (ang.) |
| Top Wall Street analysts are optimistic about the growth prospects of these 3 stocks |
TipRanks' analyst ranking service highlights three stocks favored by Wall Street, including Netflix and Intuitive Surgical. |
cnbc.com |
2025-02-02 09:16:28 |
Czytaj oryginał (ang.) |
| Is Intuitive Surgical Stock a Buy? |
Intuitive Surgical (ISRG 1.30%) capped off a record-breaking 2024 with a blowout fourth-quarter earnings report. For the period ended Dec. 31, the medical technologies (medtech) giant delivered adjusted earnings per share (EPS) of $2.21, well above the $1.79 consensus Wall Street estimate. |
fool.com |
2025-01-31 10:12:00 |
Czytaj oryginał (ang.) |
| Up 950% Over the Past Decade, This Hot Stock Just Saw Its Revenue Soar. Is It Still a Buy? |
Over the past decade, Intuitive Surgical (ISRG -0.58%) has proven to be a long-term winner in the healthcare sector. The stock is up more than 950% in that time frame, and more than 60% over the past year. |
fool.com |
2025-01-28 12:15:00 |
Czytaj oryginał (ang.) |
| Is ISRG a Buy After Logging Robust System Placements in Q4? |
Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The stock has also gained during the past month. |
zacks.com |
2025-01-28 09:21:32 |
Czytaj oryginał (ang.) |
| Buy, Sell, Or Hold ISRG Stock At $585? |
Intuitive Surgical (NASDAQ: ISRG) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of $2.2 billion and $1.79, respectively. |
forbes.com |
2025-01-28 07:00:00 |
Czytaj oryginał (ang.) |
| Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know |
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store. |
zacks.com |
2025-01-27 12:01:26 |
Czytaj oryginał (ang.) |
| Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education |
SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced a $45 million gift to the Intuitive Foundation that will be used to support the Foundation's mission of reducing the global burden of disease and suffering through philanthropy, research, and education aimed at better outcomes for patients everywhere. |
globenewswire.com |
2025-01-27 11:00:00 |
Czytaj oryginał (ang.) |
| Prediction: This Company Will Have a Trillion-Dollar Market Cap by 2040 |
The list of companies with market caps of $1 trillion or more remains extremely short. However, there's little doubt that more companies will join this elite group over the coming decades. |
fool.com |
2025-01-26 09:57:00 |
Czytaj oryginał (ang.) |
| Intuitive Announces Executive Leadership Changes to Support Continued Global Growth |
Three executive vice president promotions strengthen core company strategic leadership Three executive vice president promotions strengthen core company strategic leadership |
globenewswire.com |
2025-01-03 11:15:00 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) Ascends While Market Falls: Some Facts to Note |
Intuitive Surgical, Inc. (ISRG) reachead $524.03 at the closing of the latest trading day, reflecting a +0.4% change compared to its last close. |
zacks.com |
2025-01-02 21:12:32 |
Czytaj oryginał (ang.) |
| Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report? |
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2025-01-01 15:15:27 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It |
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store. |
zacks.com |
2024-12-31 12:16:39 |
Czytaj oryginał (ang.) |
| 5 MedTech Stocks That Are Poised to Beat the Market in 2025 |
Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices. |
zacks.com |
2024-12-30 12:01:38 |
Czytaj oryginał (ang.) |
| 2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now |
A few different elements can make a stock a no-brainer buy. The company could be the leader in its market, or well diversified across various markets. |
fool.com |
2024-12-28 06:15:00 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts |
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $538.83, indicating a +0.34% shift from the previous trading day. |
zacks.com |
2024-12-26 21:06:17 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) Declines More Than Market: Some Information for Investors |
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $523.91, moving -0.49% from the previous trading session. |
zacks.com |
2024-12-19 20:55:35 |
Czytaj oryginał (ang.) |
| Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know |
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store. |
zacks.com |
2024-12-17 12:00:57 |
Czytaj oryginał (ang.) |
| Prediction: 2 Stocks That'll Be Worth More Than Palantir 5 Years From Now |
What's the hottest S&P 500 stock of 2024? Palantir Technologies (PLTR -0.42%) is the hands-down winner. |
fool.com |
2024-12-17 08:07:00 |
Czytaj oryginał (ang.) |
| Top 3 Robotics and Automation Stocks for the Next AI Boom |
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. |
marketbeat.com |
2024-12-13 10:08:04 |
Czytaj oryginał (ang.) |
| The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen |
Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen are included in this Analyst Blog. |
zacks.com |
2024-12-12 05:16:11 |
Czytaj oryginał (ang.) |
| 5 Medical Device Stocks That Survived the 2024 Market Volatility |
Here, we discuss five medical device stocks, namely ISRG, GMED, GKOS, VCYT and INGN, which gained in 2024 despite ongoing challenges and provide an attractive investment opportunity for 2025. |
zacks.com |
2024-12-11 10:55:37 |
Czytaj oryginał (ang.) |
| Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock |
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store. |
zacks.com |
2024-12-06 12:05:36 |
Czytaj oryginał (ang.) |
| ISRG Stock Reaches All-Time High: Strength in Uptrend to Continue? |
Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The has stock also gained during the past month. |
zacks.com |
2024-12-06 11:56:13 |
Czytaj oryginał (ang.) |
| Meta-analysis published in Annals of Surgery shows benefits of da Vinci surgery across seven oncologic procedures compared to laparoscopic and open |
Analysis included 230 studies—a mix of randomized, prospective, and database research SUNNYVALE, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:ISRG) The peer-reviewed Annals of Surgery published a meta-analysis of 30-day surgical outcomes across seven oncological surgical procedures, comparing robotic, laparoscopic, and open surgical approaches. |
globenewswire.com |
2024-12-05 18:15:00 |
Czytaj oryginał (ang.) |
| Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know |
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $549.80, marking a +1.49% move from the previous day. |
zacks.com |
2024-12-04 20:51:03 |
Czytaj oryginał (ang.) |
| Investing strategies in energy, aerospace, and health |
Pointwealth Capital Management CEO & Founder Sandra Cho joins Wealth to discuss her top stock picks across energy, aviation, and healthcare sectors. In the energy sector, Cho highlights Chevron (CVX) and ExxonMobil (XOM), emphasizing that they "really have valuation potential. |
youtube.com |
2024-12-03 18:40:41 |
Czytaj oryginał (ang.) |
| Intuitive Surgical (ISRG) Upgraded to Buy: Here's What You Should Know |
Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2024-12-03 15:06:23 |
Czytaj oryginał (ang.) |
| Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos |
Last year, Morgan Stanley upgraded its outlook for the U.S. MedTech sector to “Attractive,” believing the concerns around GLP-1s were already reflected in stock prices and that fundamentals were strong. |
benzinga.com |
2024-12-02 16:29:58 |
Czytaj oryginał (ang.) |